Rs 30,800 / VialGet Latest Price Product Details: Are you looking to buy a high-potency dual-agonist peptide compound engineered to optimize your metabolic rate, achieve advanced glycemic control, and support significant weight management goals
A small study of intravenous BPC-157 for interstitial cystitis reported no adverse effects in 12 treated patients
However, Novo Nordisk pointed out that the study primarily focused on diabetes patients taking a low dose of semaglutide, rather than typical weight-loss use, for which the company's higher-dose Wegovy pill is approved
However, those with active ulcers or a history of severe gastrointestinal disease should consult their healthcare provider before starting treatment
Back Diem, P, Ducluzeau, PH, Scheen, A (Jan-March 2022) 'The discovery of insulin', Diabetes, Epidemiology and Management , 5, 100049